How to Use Clinical Trials
I’m writing this as someone who loves a person who was just told the words none of us are ever ready to hear:
brain cancer.
If you’re newly diagnosed (or you’re the one holding their hand through it), I want you to know two things can be
true at the same time:
-
This is terrifying.
-
You still have options worth exploring.
One of the most important options to understand early is clinical trials.
Why clinical trials matter (in real-life terms)
Clinical trials aren’t “last resort” or “human guinea pig” stuff. They’re simply how medicine moves forward—and
sometimes, they’re how your care moves forward too.
Here’s why they matter:
-
They can open doors to treatments you can’t get otherwise. New therapies, new combinations, new
approaches—trials are often where those live first.
-
They can give you more choices, not fewer. Even if you never enroll, learning what’s out there helps you
make more informed decisions.
-
They can be a second set of eyes on the plan. Trial screening forces a careful review of diagnosis details,
imaging, labs, prior treatments—sometimes it catches things worth discussing.
-
They can offer hope that’s grounded in action. Not “miracle” hope. The kind where you say: We’re doing
everything we reasonably can.
What clinical trials are NOT
Let me say this plainly, because fear loves vague shadows:
-
A trial is not a promise.
-
A trial is not always better than standard treatment.
-
A trial is not “giving up."
-
A trial is not something you should feel pressured into.
It’s a tool. One more lever you can pull.
The practical steps (simple, doable, no overwhelm)
If you’re in that early whirlwind, here’s a clean way to approach it:​
1) Ask for the exact diagnosis details (write them down)
These details matter for eligibility: - Tumor type (glioblastoma, astrocytoma, oligodendroglioma, etc.) - Grade - IDH
status - MGMT methylation - 1p/19q codeletion (if relevant) - Any key mutations your team tested for
2) Decide your “trial window”
Trials can be available at different moments: - Newly diagnosed (before/during/after first-line treatment) -
Recurrent/recurring (if the tumor returns)
Ask your doctor: - “Are there trials we should consider now, before we start anything?” - “If not now, what’s the best
time to revisit trials?”
3) Use ClinicalTrials.gov (and don’t be intimidated)
This is the main public registry: - https://clinicaltrials.gov/
Tips that help: - Search your exact diagnosis (example: “glioblastoma newly diagnosed”) - Filter by Recruiting (and
sometimes “Active, not recruiting” if you’re planning ahead) - Every study has an NCT number (that’s your tracking
code)
4) Call and ask the 3 questions that save time
When you find a trial that looks promising, ask: - “Are you actively enrolling right now at this location?” - “Based
on what I’m sharing, do we sound potentially eligible?” - “What are the biggest exclusion criteria that usually
rule people out?”
5) Protect your energy (this is a marathon)
If you’re the patient: you don’t have to carry this. If you’re the loved one: this is one of the most meaningful ways
you can help.
A simple division of labor: - Loved one: searches, tracks NCT numbers, makes calls - Patient: focuses on rest,
appointments, decisions with the care team
A gentle word to the newly diagnosed
If you’re reading this with shaky hands and a racing mind: you’re not behind. You’re not failing. You’re not “doing it
wrong” because you can’t process everything today.
Clinical trials are not a homework assignment. They’re a resource—and you can approach them one step at a
time.
A gentle word to the caregiver/loved one
Your job isn’t to be perfect. Your job is to be present.
Sometimes “present” looks like: - taking notes - asking the extra question - making the phone call - creating a tiny
bit of order in the chaos
That matters more than you know.
Copy/paste comment for under a trials list
“If you’re newly diagnosed, ask your team about clinical trials early—just to know your options. Use the NCT
number to find the official listing on ClinicalTrials.gov, and always confirm eligibility + open sites with your
care team.”